QuickView for dihydropyrimidine dehydrogenase (NADP+) activity (biogroup)

1. Ovarian cancer cell lines treated with HGF and cisplatin, dominant-negative p38, or CSE1L siRNA
2. OMIM - Congenital disorder
3. OMIM - Metabolic disease
4. SK-OV-3, TOV-21G and NIH OVCAR-3 ovarian cancer cells treated with cisplatin
5. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)

There were no matches for dihydropyrimidine dehydrogenase (NADP+) activity

1. A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects Wi…
2. A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy…
3. A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular…